IXJ Fees and Costs — iShares Global Healthcare ETF
Data updated: 2026-08-24
The net expense ratio is 0.40%: a 0.39% management fee plus 0.01% other expenses. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $27K in broker commissions, 0.0007% of average net assets, and portfolio turnover was 5%.
IXJ Fees and Expenses
Annual operating expenses and sales charges of IXJ. Prospectus, as of March 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.39% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.01% |
| Gross expense ratio | 0.40% |
| Fee waiver | — |
| Net expense ratio | 0.40% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
IXJ Costs Over Time
On $10,000 invested in IXJ, assuming 5% a year before costs, total costs come to $254 over 5 years, cutting the return by 0.42% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.40%) | $42 | $132 | $230 |
| Trading costs (broker commissions) | $0 | $0 | $0 |
| Lost growth on money paid in costs | $0 | $7 | $23 |
| Total costs | $42 | $139 | $254 |
| Value after costs | $10,458 | $11,438 | $12,509 |
| Impact on return, per year | 0.42% | 0.42% | 0.42% |
IXJ Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0007%
- Total broker commissions: $27K
- Bought from dealers (principal trades, not a cost): $2.0B
- Portfolio turnover (prospectus): 5%
- Securities on loan, average value: $12.0M
- Net income from securities lending: $56K (0.001% of average net assets)
IXJ Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $4K | 15.95% |
| BofA Securities, Inc. | $4K | 14.92% |
| HSBC Securities (USA) Inc. | $3K | 13.11% |
| Citigroup Global Markets Inc. | $3K | 11.90% |
| UBS Securities LLC | $3K | 11.57% |
| BNP Paribas Securities Corp. | $2K | 7.90% |
| RBC Capital Markets, LLC | $2K | 7.28% |
| Morgan Stanley & Co. LLC | $2K | 6.87% |
| Barclays Capital Inc. | $1K | 5.92% |
| Goldman Sachs & Co. LLC | $1K | 4.59% |
IXJ Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $584.0M | 28.56% |
| BofA Securities, Inc. | $464.7M | 22.73% |
| UBS Securities LLC | $405.1M | 19.81% |
| BlackRock Funds III - BlackRock Cash Funds: Treasury | $292.6M | 14.31% |
| Jane Street Capital, LLC | $155.2M | 7.59% |
| Citigroup Global Markets Inc. | $60.4M | 2.95% |
| MIZUHO SECURITIES | $45.1M | 2.20% |
| Goldman Sachs & Co. LLC | $37.7M | 1.84% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.